Someone noted on the Cytodyn facebook page that our Covid

New Post Public Reply Private Reply Replies (0) Message Board
Evil Rabbit
714
Someone noted on the Cytodyn facebook page that our Covid trials now read as "in progress" on the website.

Can anyone confirm that's different from what it read previously?

Did it say "on hold" or something to that effect while the stinky FDA banner was smeared on every page?

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

JJ Lin's Iconic Singapore Grand Prix Show With 20 Songs

Updated Category News Views 3

Nothing beats the thrill of a live performance under a night sky, with the adrenaline of a Formula 1 race still in the air. On October 9, 2026, Mandopop superstar JJ Lin captivated the crowd at the Padang Stage of the Singapore Grand Prix, delivering not just a concert but a spectacle of international scale. Stage Spectacle with Precision JJ Lin took control like a...

Continue Reading
Baidu Faces Securities Fraud Lawsuit: Key Investor Alert

Updated Category News Views 6

Stormy Weather for Baidu Investors Digging through the latest on Baidu's (NASDAQ:BIDU) unsettling journey feels like watching a rerun of a soap opera you wish would just end. The company has been slapped with a class action lawsuit by The Law Offices of Frank R. Cruz, accusing them of pulling the wool over investors' eyes from November 18, 2025, to August 17, 2026....

Continue Reading
Mendocino Farms Faces Allegations Over Employee Practices

Updated Category News Views 8

Mendocino Farms Lands in Legal Hot Water Jobs pay the bills and keep the gears turning. But when a company like Mendocino Farms allegedly chucks out the rulebook, things get messy fast. We're talking about a hefty lawsuit aimed at this chain, accusing them of playing fast and loose with California's labor laws. If you've been around the block like me, you know that...

Continue Reading
Italian Excellence: NYC Celebrates Innovators and Icons

Updated Category News Views 41

The Fusion of Italian Artistry and Innovation Imagine blending business savvy with a touch of culture and ethics. That's the spirit of the 9th Business Care International Award, which is gearing up to hit New York City's grand stage come November 18-19. This ain't just about pats on the back; it's a recognition of those who push Italian excellence across oceans and into...

Continue Reading
Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 2

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Utility Switching for UK SMEs: More Than Just Price

Updated Category News Views 5

Beyond the Price Tag: The Real Game of Utility Switching The grind for small and medium enterprises (SMEs) in the UK ain't just about finding the cheapest deals; it's about securing the right ones. Better Business Advice has highlighted Love Business for precisely this reason. They're helping companies navigate the complex web of commercial utility contracts—broadband,...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 5

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 3

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
Dott's Q3 2026: Micromobility Growth Soars High

Updated Category News Views 7

Riding the Wave of Profit in Micromobility Sometimes all you need is a quick jolt of genius to turn the wheels of fortune. Dott seems to have hit that sweet spot in Q3 of 2026. Deploying 45,000 new vehicles wasn’t just a logistical feat; it was a calculated bet that paid off handsomely, bolstering their business to soaring heights. Performance that Packs a Punch The Q3...

Continue Reading
S&P Global's New Dashboard: Unpacking Data Insights

Updated Category News Views 3

An Interactive Take on Digital Infrastructure The geniuses over at S&P Global Ratings have just unleashed a shiny new tool for number crunchers and market hawks who can't get enough data center action—an interactive dashboard. Maybe not everyone’s cup of tea, but hey, in the dog-eat-dog world of digital infrastructure, any edge counts. What's in the Data Center Soup?...

Continue Reading

Top 5 Most Recently Viewed Articles

M7 World Championship 2025: A New Era for Esports in Indonesia

Updated Category News Views 153

M7 World Championship 2025: A New Era for Esports in Indonesia The stage is set for the M7 World Championship—a monumental event poised to showcase Indonesia as a hub for global esports. This year, the championship promises to amplify the excitement surrounding Mobile Legends: Bang Bang (MLBB) Esports through a series of thrilling matches and vibrant cultural...

Continue Reading
James Hardie Industries Faces Class Action – Key Details Inside

Updated Category News Views 142

James Hardie Industries plc. Class Action Lawsuit Overview Investors in James Hardie Industries plc. (NYSE: JHX) are being alerted to an important class action lawsuit that is currently underway. This lawsuit aims to address concerns over alleged securities fraud that impacted shareholders. Understanding the Class Action Details The lawsuit's objective is to seek...

Continue Reading
Embla Medical Reports Impressive Growth in Q3 2024 Results

Updated Category News Views 152

Embla Medical Delivers Strong Q3 2024 Performance Sveinn Sölvason, President and CEO of Embla Medical hf, has shared positive updates regarding the company’s performance in the third quarter of 2024. With an impressive sales figure of USD 214 million, the company has demonstrated consistent organic growth of 7% compared to the same quarter in the previous year. Sales...

Continue Reading
Standex Invites Investors to Discuss Q1 Fiscal 2025 Updates

Updated Category News Views 188

Standex International Corporation Announces Investor Call Standex International Corporation (NYSE: SXI) has officially scheduled an important investors' conference call to discuss its first quarter fiscal 2025 financial results. This call is set for the morning and will also cover the recent acquisition of Amran Instrument Transformers and Narayan Powertech Pvt. Ltd....

Continue Reading
Douglas Elliman Welcomes New Executive: Key Financial Insights

Updated Category News Views 274

Douglas Elliman's New Appointment and Its Implications Douglas Elliman Inc. (NYSE:DOUG), a leading real estate agency, has officially announced a significant change in its executive team. This change comes as the company moves forward with a fresh strategy aimed at enhancing its market position. James Bryant Kirkland III has been appointed as the Executive Vice President,...

Continue Reading